In The Name of God. Multiple Sclerosis and Normal MRI new modalities for problems solving.

Slides:



Advertisements
Similar presentations
Inflammation and Neurodegeneration in Multiple Sclerosis
Advertisements

Corpus Callosum Damage Predicts Disability Progression and Cognitive Dysfunction in Primary-Progressive MS After Five Years.
A&P Signs & Symptoms Management of condition
Diffusion-Weighted Imaging in Magnetic Resonance Imaging for prostate gland in Malaysian males with high prostate specific antigen in the diagnosis of.
In The Name of Allah The Most Beneficent The Most Merciful
Study Design 121 Relapsing-remitting MS patients randomized to –Stress Management Therapy MS active treatment* 16 individual sessions conducted over 24.
Richard Simmons, M.D. Child Neurologist Schenectady Neurological Consultants.
Neuroradiology Natasha Wehrli, MS4 University of Pennsylvania School of Medicine.
Does early Computerised Tomography exclude fracture in ‘Clinical Scaphoid Fracture’? Dr. Mark Harris Dr Jaycen Cruickshank Department of Orthopaedics,
Neuroradiology Dr Mohamed El Safwany, MD. Intended Learning Outcomes  The student should be able to understand role of medical imaging in the evaluation.
Assistant Lecturer Of Neurosurgery, Alexandria, Egypt Alex Neuro 2014.
MILD TRAUMATIC BRAIN INJURY IN PATIENTS WITH VASCULAR DEMENTIA Yuri Alekseenko Department of Neurology and Neurosurgery Vitebsk Medical University Vitebsk,
Diagnosing – Critical Activity HINF Medical Methodologies Session 7.
Multiple Sclerosis Definition: Multiple sclerosis (MS) is a disease of the central nervous system (CNS); it damages the protective coating around the.
Original Article B-Cell Depletion with Rituximab in Relapsing- Remitting Multiple Sclerosis Stephen L. Hauser, M.D., Emmanuelle Waubant, M.D., Ph.D., Douglas.
Early detection of pulmonary involvement in scleroderma patients By Mohamed Mostafa Metwally, MD, FCCP Assistant professor of chest diseases Assiut University.
Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.
Multiple Sclerosis (MS) By: Morgan Farr Biology 1010.
Multiple Sclerosis (Definition)  “Multiple Sclerosis is a progressive demyelination of neurons in the central nervous system (the Brain and the Spinal.
Multiple Sclerosis BY: SARAH BURGESS. “For every male that is diagnosed with multiple sclerosis there is three women diagnosed”
A ACHOUR, S JERBI OMEZZINE, S YOUNES 1, S BOUABID, MH SFAR 1, HA HAMZA. Department of Medical Imaging, Tahar Sfar University Hospital Center, Mahdia, Tunisia.
Multiple sclerosis James parker. What is multiple sclerosis Multiple sclerosis is a It is a chronic disease affecting more women than men often leading.
Adam Percey. What is it?  MS is a disease of the central nervous system.  What happens is the myelin sheaths around the axon of a nerve fade away. These.
Multiple Sclerosis Rohith M. Reddy. Multiple sclerosis (MS) involves an immune-mediated process in which an abnormal response of the body’s immune system.
Multiple Sclerosis Brett Catlin Period Seven September 3 rd, 2003.
Initial presentation of multiple sclerosis in northern Iran; Is there any comparison to other countries Initial presentation of multiple sclerosis in northern.
Multiple Sclerosis Alan Chen 4/1/14. General Information Other names: disseminated sclerosis or encephalomyelitis disseminata Inflammatory disease that.
© 2014 Direct One Communications, Inc. All rights reserved. 1 A New Era of Therapy in Multiple Sclerosis: Balancing the Options and Challenges Ahead Jennifer.
Genetic Variation Influences Glutamate Concentrations in Brains of Patients with Multiple Sclerosis Robby Bonanno.
Sagittal FLAIR images - Stable nonenhancing hyperintensities within the pericallosal white matter and bilateral centrum semiovale, consistent with known.
MS: A Perspective on the African American Experience Mary D. Hughes, MD Medical Director, Neuroscience Associates University Medical Group Greenville Hospital.
1 SCREENING. 2 Why screen? Who wants to screen? n Doctors n Labs n Hospitals n Drug companies n Public n Who doesn’t ?
Updates on Optic Neuritis Briar Sexton Neuro-ophthalmology Clinical Day Friday, November 18, 2005.
MULTIPLE SCLEROSIS Ana Costas Barreiro.
References: [1]S.M. Smith et al. (2004) Advances in functional and structural MR image analysis and implementation in FSL. Neuroimage 23: [2]S.M.
Neuroplasticity and Rehabilitation Strategies Robert K. Shin M.D. VA MS Center of Excellence Assistant Professor Departments of Neurology and Ophthalmology.
Jalal Jalal Shokouhi-MD General secretary of Iranian society of Radiology
IsotropicAnisotropic ROLE OF DIFFUSION TENSOR IMAGING (DTI) IN INTRACRANIAL MASSES Abstract Number: 117.
CASE 1 Olivia Clements, Cade Mersch, and Julia Calhoun.
Dennis Bourdette, MD VA MS Center of Excellence-West and
White Matter Structural Integrity in Healthy Aging Adults and Patients With Alzheimer Disease: A Magnetic Resonance Imaging Study Bartzokis, et al. UCLA.
COMPARATIVE LATERALIZING ABILITY of MULTIMODALITY MR IMAGING in TEMPORAL LOBE EPILEPSY ¹ Karabekir Ercan, M.D. ¹ ¹ H.Pinar Gunbey, M.D. ¹ ¹ Elcin Zan,
Diffusion Magnetic Resonance Imaging (dMRI) Meysam Golmohammadi.
Magnetic Resonance Imaging In Young Patients With Neuro - Psychiatric SLE : A Case Series Dr. Vivek Gupta Department of Radiodiagnosis Postgraduate Institute.
Electrophysiology & Leukodystrophies Shahriar Nafissi Department of Neurology Tehran University of Medical Sciences.
Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of Anti-CD25 Antibody Daclizumab in the Inhibition.
Multiple Sclerosis (MS) a serious, chronic and debilitating disease What is MS? A disease of the brain and spinal cord.
STUDY ON THE LEVELS OF TAU AND β-AMYLOID IN CSF OF PATIENTS WITH MULTIPLE SCLEROSIS Levente Szalárdy MD Department of Neurology University of Szeged Hungary.
Multiple Sclerosis. What is MS? This is a chronic and often disabling disease in which the body’s immune system (t-cells) attacks the central nervous.
MR SPECTROCOPY AND MRI TO MEASURE TREATMENT OF NEURODEGENERATION MICHAEL W. WEINER Professor of Radiology, Medicine, Psychiatry, and Neurology, U.C.S.F.
Spectroscopy of the Brain in Primary Lateral Sclerosis J. Taylor 4, D. Powell 2,3, H. Chebrolu, 1,3 A. Andersen 2,3, E. Kasarskis 1, C.D. Smith 1,2,3 1.
MAGNETIC RESONANCE IMAGING by PRADEEP V.EPAKAYAL. Mem.no L.
Multiple Sclerosis. Multiple sclerosis (MS) is a disease that affects central nervous system (brain and spinal cord). It damages the myelin sheath. 
CATEGORY: IMMUNE DYSFUNCTION Multiple Sclerosis Lindsay Nicholson, University of Bristol, UK [ Multiple sclerosis (MS) is.
Yael Hacohen, Kshitij Mankad, W
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease  C Bjartmar, J.R Wujek, B.D Trapp  Journal of.
Restriction Spectrum Imaging in Multiple Sclerosis
Four Known Types of MS Clinically isolated syndrome (CIS)
Multiple Sclerosis [
CORRELATION OF BIOMARKERS FOR AXONAL DEGENERATION WITH RETINAL NERVE FIBER LAYER THICKNESS AND DISABILITY IN DIFFERENT PHASES OF MULTIPLE SCLEROSIS UZUNKOPRU.
Evidence-Base Medicine
Neuro-ophthalmology.
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) and Review of Literature Zebin Xiao Department of.
What’s the Big Deal About Brain Atrophy and Neurodegeneration in RRMS?
Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Associations of [11C](R)-PK11195 binding to disability and diffusion tensor imaging (DTI) changes in patients with MS Associations of [11C](R)-PK11195.
Nat. Rev. Neurol. doi: /nrneurol
Figure 4 Comparison of 7.0T and 3.0T MRI (patients 5 and 6)‏
Figure 1 Illustration of white matter– and lesion-associated regions of interest (ROIs)‏ Illustration of white matter– and lesion-associated regions of.
In the name of GOD.
Presentation transcript:

In The Name of God

Multiple Sclerosis and Normal MRI new modalities for problems solving

Multiple Sclerosis (MS) Is not a proclamation and religious diagnosis. Is not a proclamation and religious diagnosis. Is not purely a “ evidence- based medicine ” dependent diagnosis. Is not purely a “ evidence- based medicine ” dependent diagnosis. But it is a improvisational and really have a dynamic process for diagnosis. But it is a improvisational and really have a dynamic process for diagnosis.

Why ? We want to insert MS at our differential diagnosis in most of times. We want to insert MS at our differential diagnosis in most of times.

Because: MS is a heterogeneous disease and like to TB and Zigma is a great imitator. MS is a heterogeneous disease and like to TB and Zigma is a great imitator. We can not practice with principle of parsimony or Occam ’ s Razor at all of times. We can not practice with principle of parsimony or Occam ’ s Razor at all of times. MS have high prevalence, specially young peoples and reported in two limits of age. MS have high prevalence, specially young peoples and reported in two limits of age.

Why ? Occasionally we fear to insert MS at our differential diagnosis list. Occasionally we fear to insert MS at our differential diagnosis list.

Because: Many important alternative diagnosis (specially vascular and leukodystrophy in two age limits) Many important alternative diagnosis (specially vascular and leukodystrophy in two age limits) High prevalence of MS and frightening from overdiagnosis. High prevalence of MS and frightening from overdiagnosis. Many differentials of MS have similar clinical and paraclinical manifestations. Many differentials of MS have similar clinical and paraclinical manifestations. Unusual manifestation (MS variants). Unusual manifestation (MS variants). Finally, a normal MRI. Finally, a normal MRI.

MRI (importance) Magnetic resonance imaging may even assist in earlier diagnosis of multiple sclerosis by enabling visualization of lesions in the brain that are clinically silent. Magnetic resonance imaging may even assist in earlier diagnosis of multiple sclerosis by enabling visualization of lesions in the brain that are clinically silent.

LIMITED ROLE OF MRI IN MS MRI is sensitive but less specific for the diagnosis of MS. MRI is sensitive but less specific for the diagnosis of MS. People with presenting in the early stages of multiple sclerosis have less or no lesion. People with presenting in the early stages of multiple sclerosis have less or no lesion. Accuracy of magnetic resonance imaging varies according to presenting symptoms (spinal). Accuracy of magnetic resonance imaging varies according to presenting symptoms (spinal). These suggested that the role of magnetic resonance imaging either in ruling in or ruling out a diagnosis of multiple sclerosis is limited. These suggested that the role of magnetic resonance imaging either in ruling in or ruling out a diagnosis of multiple sclerosis is limited.

MS remains a predominantly clinical diagnosis Why, MRI should be included in the work-up of patients with multiple sclerosis? Because of: certainty of the diagnosis, ruling out differential diagnoses, providing a baseline for monitoring disease progression, patient request, and patient reassurance, insurance companies request. Because of: certainty of the diagnosis, ruling out differential diagnoses, providing a baseline for monitoring disease progression, patient request, and patient reassurance, insurance companies request.

MRI (overdiagnosis) Use of magnetic resonance imaging to confirm multiple sclerosis on the basis of a single attack may lead to over-diagnosis and over-treatment. Use of magnetic resonance imaging to confirm multiple sclerosis on the basis of a single attack may lead to over-diagnosis and over-treatment.

MRI (underdiagnosis with normal results) Neurologists should discuss with their patients about diagnosis, treatment, and ultimate effect of potential errors of false negative magnetic resonance imaging results. Neurologists should discuss with their patients about diagnosis, treatment, and ultimate effect of potential errors of false negative magnetic resonance imaging results.

What is the best approach to this problem

In the Presence of a Normal MRI ?! Usually in the absence of other problems normal MRI is not a major problem in clinical practice. Usually in the absence of other problems normal MRI is not a major problem in clinical practice.

Many important alternative diagnosis (specially vascular and leukodystrophy in two age limits) Many important alternative diagnosis (specially vascular and leukodystrophy in two age limits) High prevalence of MS and frightening from overdiagnosis. High prevalence of MS and frightening from overdiagnosis. Many differentials of MS have similar clinical and paraclinical manifestations. Many differentials of MS have similar clinical and paraclinical manifestations. Unusual manifestation (MS variants). Unusual manifestation (MS variants). Finally, a normal MRI. Finally, a normal MRI.

Because: Low percent of normal MRI(3%). Low percent of normal MRI(3%). Many clinical and paraclinical tests are suggestive. Many clinical and paraclinical tests are suggestive. New technology in brain imaging dissolve this problem today's. New technology in brain imaging dissolve this problem today's.

New MR modalities Hypointense lesions load of T1- weighted images and MR Volumetry, High Tesla MRI, MRI with GAD, Magnetization Transfer Imaging (MTI), Diffusion Tensor Imaging (DTI), and Proton Magnetic Resonance Spectroscopy (H-MRS). Hypointense lesions load of T1- weighted images and MR Volumetry, High Tesla MRI, MRI with GAD, Magnetization Transfer Imaging (MTI), Diffusion Tensor Imaging (DTI), and Proton Magnetic Resonance Spectroscopy (H-MRS).

Use of other MR modalities ? Inability of conventional MRI to accurately depict the pathology of MS as regards to histopathologic heterogeneity of MS lesions and the pathological processes occurring in the Normal Appearing White Matter (NAWM). Inability of conventional MRI to accurately depict the pathology of MS as regards to histopathologic heterogeneity of MS lesions and the pathological processes occurring in the Normal Appearing White Matter (NAWM). The limitation of T2-weighted MRI (artifacts), in delineating tissue damage occurring in CNS. The limitation of T2-weighted MRI (artifacts), in delineating tissue damage occurring in CNS.

Magnetic Resonance Spectroscopy MR Spectroscopy is being increasingly used to identify many of brain lesions and to localize areas of their pathologic involvement. MR Spectroscopy is being increasingly used to identify many of brain lesions and to localize areas of their pathologic involvement.

Magnetic Resonance Spectroscopy The nuclei of a number of atoms (H, F, Li, Na, and p) are excited by the magnetic field. The nuclei of a number of atoms (H, F, Li, Na, and p) are excited by the magnetic field. As the energy of these nuclei returns to a baseline state, a "frequency signature" particular to each nucleus can be measured. As the energy of these nuclei returns to a baseline state, a "frequency signature" particular to each nucleus can be measured. Simply put, the magnitude of each peak in this "frequency signature" corresponds to Simply put, the magnitude of each peak in this "frequency signature" corresponds to the concentration of a particular atom in the brain region being assessed. the concentration of a particular atom in the brain region being assessed.

MR Spectroscopy Recent pathology studies have stressed the Recent pathology studies have stressed the importance of axonal pathology in MS, in lesions and in Normal Appearing White Matter (NAWM). importance of axonal pathology in MS, in lesions and in Normal Appearing White Matter (NAWM). Decrease in N-Acetyl Aspartate (NAA) has been used as an marker of axonal damage or loss that presumably appears secondary to inflammation or demyelination. Decrease in N-Acetyl Aspartate (NAA) has been used as an marker of axonal damage or loss that presumably appears secondary to inflammation or demyelination.

MR Spectroscopy Loss of neurons would thus predict a persistent reduction in the levels of NAA. Loss of neurons would thus predict a persistent reduction in the levels of NAA. There are now many studies in the literature that report a reduction of NAA in acute lesions, in chronic multiple sclerosis lesions, in areas of normal appearing white matter, and in gray matter. There are now many studies in the literature that report a reduction of NAA in acute lesions, in chronic multiple sclerosis lesions, in areas of normal appearing white matter, and in gray matter.

Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy Juan Luis Ruiz- Pe ñ a et al

Background: What currently appears to be irreversible axonal loss in normal appearing white matter, measured by proton magnetic resonance spectroscopy is of great interest in the study of Multiple Sclerosis. What currently appears to be irreversible axonal loss in normal appearing white matter, measured by proton magnetic resonance spectroscopy is of great interest in the study of Multiple Sclerosis.

Background: Our aim is to determine the axonal damage in normal appearing white matter measured by magnetic resonance spectroscopy and to correlate this with the functional disability. Our aim is to determine the axonal damage in normal appearing white matter measured by magnetic resonance spectroscopy and to correlate this with the functional disability.

Methods: Thirty one patients (9 male and 22 female) with relapsing remitting Multiple Sclerosis and a Kurtzke Expanded Disability Scale Score of 0 – 5.5 were recruited from four hospitals in Andalusia, Spain and included in the study. Thirty one patients (9 male and 22 female) with relapsing remitting Multiple Sclerosis and a Kurtzke Expanded Disability Scale Score of 0 – 5.5 were recruited from four hospitals in Andalusia, Spain and included in the study. Magnetic resonance spectroscopy scans and neurological disability assessments were performed the same day. Magnetic resonance spectroscopy scans and neurological disability assessments were performed the same day.

Results: A statistically significant correlation was found (p < 0.05) between disability (measured by Expanded Disability Scale Score) and N-Acetyl Aspartate (NAA/Cr ratio) levels in normal appearing white matter in these patients. A statistically significant correlation was found (p < 0.05) between disability (measured by Expanded Disability Scale Score) and N-Acetyl Aspartate (NAA/Cr ratio) levels in normal appearing white matter in these patients.

Conclusions: There is correlation between disability (measured by Expanded Disability Scale Score) and the NAA/Cr ratio in normal appearing white matter. There is correlation between disability (measured by Expanded Disability Scale Score) and the NAA/Cr ratio in normal appearing white matter.